GHRP-2

Growth Hormone / IGF-1 Axis
Phase 2
Investigational

GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic six-amino-acid peptide that triggers growth hormone release. It is considered more potent than GHRP-6 with less appetite stimulation.

Last updated February 22, 2026
158 PubMed-Verified Studies
Niche
Research-Driven Dosage Reports
RouteSubcutaneous (SC)
Dose100–300 mcg
Frequency2–3× daily
Duration8–16 weeks

Based on published research literature.

Verified sources for GHRP-2

These vendors are vetted by PeptideWiki for purity testing and COA transparency.

SwissChems10% off
View all vendor deals·Affiliate links. Commission at no extra cost.

Overview of GHRP-2

Activates ghrelin receptors to trigger potent growth hormone release with moderate effects on appetite and cortisol.

Growth hormone axis

Binds and activates growth hormone secretagogue receptor (GHS-R1a), triggering signaling that promotes GH synthesis and release.

Produces robust, dose-dependent GH release, often considered more potent than GHRP-6 per-milligram.

Has been studied in clinical trials for GH deficiency and cachexia, with clinical research data available.

Hormonal effects

Less pronounced hunger stimulation compared to GHRP-6, which is preferred for those not seeking appetite increase.

May cause modest, transient elevations in cortisol and prolactin, which is less pronounced than with some alternatives

Read Full GHRP-2 Dosage Guide

Research-backed dosing protocols, timing, and administration details

Browse more in this category

Growth Hormone / IGF-1 Axis